Answers are grounded in this paper and cite their sources.
The GWTG-Stroke sICH risk "GRASPS" score provides clinicians with a validated method to determine the risk of sICH in patients treated with intravenous tissue-type plasminogen activator within 3 hours of stroke symptom onset.
No takes yet. Share an insight, caveat, or question.
Menon et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: